GO:0046395 carboxylic acid catabolic process

Carboxylic acids are ubiquitous organic molecules defined by the presence of one or more carboxyl (-COOH) groups, and their catabolism is essential for energy production, detoxification, and metabolic homeostasis. The Gene Ontology term GO:0046395, carboxylic acid catabolic process, captures the chemical reactions and pathways that result in the breakdown of these compounds. This process is not a single reaction but a network of enzymatic steps that convert carboxylic acids into simpler metabolites, often feeding into central carbon metabolism. Understanding this term is critical because carboxylic acid catabolism intersects with microbial pathogenesis, metabolic engineering, drug metabolism, and human disease [1,2,3,5]. For researchers, GO:0046395 provides a standardized framework to annotate genes, interpret omics data, and design experiments that probe how cells and organisms handle carboxylic acid substrates. The term is particularly relevant in studies of carboxylic acid reductases (CARs), which catalyze the ATP-dependent reduction of carboxylic acids to aldehydes and are key players in both natural and engineered catabolic routes [1,2]. In addition, carboxylic acid transporters and catabolic enzymes influence the ability of pathogens such as Candida species to survive and cause disease. In human health, alterations in carboxylic acid catabolic processes have been observed in diabetic kidney disease, where transcriptomic and proteomic changes highlight these pathways as potential biomarkers or therapeutic targets. Moreover, carboxylic acids themselves can modulate signaling pathways, such as NRF2 activation, linking their metabolism to antioxidant and anti-inflammatory responses. The study of carboxylic acid catabolism also has practical implications for drug development, as metabolic activation of carboxylic acids can produce reactive intermediates, and hydroxamic acid groups can be metabolized to carboxylic acids via oxidation or hydrolysis [7,8]. Thus, GO:0046395 is a cornerstone term for understanding both fundamental biochemistry and translational applications.

GO:0046395 carboxylic acid catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups. This biological process encompasses enzymatic steps that modify or cleave the carboxyl group, often converting the parent compound into aldehydes, alcohols, or smaller acids that can enter central metabolic pathways. Synonyms include carboxylic acid breakdown, carboxylic acid catabolism, and carboxylic acid degradation.

Carboxylic acid catabolic process is important because it governs the fate of a vast array of organic acids that are central to cellular energy production, detoxification, and biosynthetic precursor supply. In microorganisms, these pathways determine the ability to utilize diverse carbon sources and can influence virulence, as seen in Candida pathogenesis where carboxylic acid transporters and catabolic enzymes are critical. In metabolic engineering, carboxylic acid reductases (CARs) are harnessed to convert carboxylic acids into valuable aldehydes and alcohols, enabling sustainable production of fuels and chemicals. In human health, dysregulation of carboxylic acid catabolism has been linked to diabetic kidney disease, where altered protein translation and carboxylic acid catabolic processes are observed. Additionally, carboxylic acids can act as signaling molecules, such as NRF2 activators with antioxidant and anti-inflammatory effects, and their metabolism is relevant to drug design and toxicology [6,7,8]. Therefore, understanding GO:0046395 is essential for both basic biology and translational research.

The following genes and proteins are experimentally implicated in carboxylic acid catabolic process, based on published literature.

Carboxylic acid catabolic process is regulated at multiple levels, including transcriptional control, enzyme activation, and substrate availability. The transcription factor NRF2 is activated by carboxylic acids and coordinates antioxidant and anti-inflammatory gene expression, linking catabolic flux to cellular stress responses. In diabetic kidney disease, alterations in protein translation and carboxylic acid catabolic processes suggest that these pathways are subject to translational and post-translational regulation. Additionally, hydroxy-carboxylic acid receptors (HCARs) sense carboxylic acid derivatives and modulate metabolic and inflammatory signaling. In microorganisms, carboxylic acid transporters are regulated in response to carbon source availability and host signals, contributing to pathogenesis. Enzyme activities of carboxylic acid reductases are also controlled by cofactor availability (ATP, NADPH) and substrate specificity [1,2].

Diabetic kidney disease is associated with alterations in protein translation and carboxylic acid catabolic processes. Transcriptomic and proteomic analyses have revealed dysregulation of these pathways, suggesting that carboxylic acid catabolism may contribute to disease progression or serve as a biomarker.

Carboxylic acid transporters in Candida species are required for uptake of carboxylic acids and are important for pathogenesis. Disruption of these transporters reduces virulence, highlighting the role of carboxylic acid catabolism in fungal infections.

Carboxylic acids can undergo metabolic activation to reactive intermediates, leading to toxicity. The metabolism of hydroxamic acid groups to carboxylic acids via oxidation or hydrolysis is a key consideration in drug design and safety assessment [7,8].

Hydroxy-carboxylic acid receptors (HCARs) mediate metabolic and inflammatory effects of carboxylic acids, and NRF2 activation by carboxylic acids provides antioxidant and anti-inflammatory benefits. Dysregulation of these pathways may contribute to metabolic disorders [4,6].

Enzyme assays using purified carboxylic acid reductases or cell lysates can measure catalytic activity and substrate specificity. Metabolomics approaches, such as LC-MS, quantify carboxylic acid levels and flux through catabolic pathways, providing a snapshot of pathway activity [2,5].

RNA-seq and proteomics can identify genes and proteins differentially expressed during carboxylic acid catabolism. In diabetic kidney disease, such approaches revealed alterations in protein translation and carboxylic acid catabolic processes. These methods are useful for discovering novel regulators and biomarkers.

CRISPR knockout, point mutation, and knock-in models enable precise interrogation of genes involved in carboxylic acid catabolism. For example, knocking out carboxylic acid transporters in Candida can test their role in pathogenesis. Genome-wide CRISPR screens can identify novel genes required for growth on carboxylic acids as sole carbon sources.

Fluorescent reporters and isotope tracing can visualize carboxylic acid uptake and catabolic flux in live cells. These methods complement biochemical assays and provide spatial and temporal resolution of the pathway.

Researchers studying carboxylic acid catabolic process-related genes often need to determine whether a candidate gene is causally involved in substrate breakdown, flux regulation, or disease-associated phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling functional validation of genes in the carboxylic acid catabolic process.

GO:0046395 carboxylic acid catabolic process is a fundamental biological process that governs the breakdown of organic acids in all domains of life. Its importance spans energy metabolism, detoxification, microbial pathogenesis, metabolic engineering, and human disease. Key enzymes such as carboxylic acid reductases and transporters have been structurally and functionally characterized, and their roles in conditions like diabetic kidney disease and Candida infections are emerging [1,2,3,5]. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of new genes and regulatory mechanisms. EDITGENE provides the tools to dissect this pathway with precision, from knockout and point mutation to knock-in and overexpression models, empowering researchers to translate basic findings into therapeutic and biotechnological applications.